Comparison of flow cytometric DNA content analysis in fresh and paraffin-embedded ovarian neoplasms: a prospective study. by Eissa, S. et al.
British Joumal ofCancer(1998) 77(3), 421-425
0 1998 Cancer Research Campaign
Comparison of flow cytometric DNA content analysis
in fresh and paraffin-embedded ovarian neoplasms:
a prospective study
Sanaa Eissa1, A Khalifal, M Laban2, A Elian2 and WE Bolton3
'Oncology Diagnostic Unit (Biochemistry Department) and 2Department of Gynecology, Ain Shams Faculty of Medicine, Cairo, Egypt; 31mmunology Research
and Technology, Coulter Corporation, Miami, FL, USA
Summary DNA ploidy analysis was performed on both fresh and paraffin-embedded preparations from each of 54 malignant ovarian
neoplasms. Aneuploidy was detected in both the fresh and the paraffin-embedded tissue in 19 out of 54 (35%) malignant cases. In addition,
aneuploidy was detected exclusively in fresh tissue in seven of the malignant cases, and exclusively in paraffin-embedded tissue in one ofthe
malignant cases, yielding a total of 27 out of 54 (50%) aneuploid cases. The correlation coefficient (r-value) for fresh and paraffin-embedded
tissue ploidy analysis in the malignant specimens was 0.91. Although the frequency of recurrence was higher and overall survival lower in the
malignant aneuploid specimens of both types, the combined analysis of DNA and survival rates indicated superior prognostic significance of
fresh tissue. Of the seven patients in whose specimens aneuploidy was detected exclusively in fresh tissue, all died of recurrent disease
during the follow-up period. Ourfinding indicates that data generated byflow cytometry analysis of formalin-fixed tissue should be interpreted
with caution before the data can be used to draw clinical inferences.
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As evidence mounts that aneuploidy predicts a poor clinical
outcome (Barlogie et al, 1980), flow cytometry (FCM) is increas-
ingly being used in DNA analysis to determine ploidy and prolif-
eration rate in a variety ofhuman neoplasms. Initially, the method
was based upon examination ofnuclear suspensions obtained from
fresh or frozen material. Recently, however, numerous reports
have confirmed flow cytometric detection of aneuploid sub-
populations in paraffin-embedded tissues from human neoplasms
(Schutte et al, 1985; Coon et al, 1986; Danova et al, 1988; Hedley,
1989). The useofarchival specimens has the importantadvantages
ofallowing rapid access to large numbers ofspecific tumours, and
correlation with survival and treatment response data.
However, the question of whether the results obtained from
fresh and paraffin-embedded tissues are comparable remains to be
resolved. Although a few studies have examined DNA ploidy in
both types of samples in small numbers of cases of particular
tumours, such as melanoma and urogenital, bladder, lung, gastric,
breast, haematopoietic, and lymphoid neoplasms (Camplejohn and
Macartney, 1985; Nakamura et al, 1987; Jacobsen et al, 1988a,b;
Klami and Joeysuu, 1988; Grignon et al, 1989; Isobe et al, 1990;
Plestring et al, 1990; De Viata et al, 1991; Krause and Blank,
1992), most studies have been restricted to either paraffin-
embedded or fresh tissues.
The aim of the present study was to address this issue by
comparing DNA ploidy analysis in parallel fresh and paraffin-
embedded preparations from each of 82 ovarian tumours, with
evaluation ofthe prospective prognostic significance in both cases.
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MATERIAL AND METHODS
Patients
Between May 1991 and March 1997 tissue samples were obtained
from 54 women with primary malignant ovarian carcinoma and 28
women with benign ovarian neoplasm. All the malignant group
were staged according to systems adopted by the International
Federation of Gynecology and Obstetrics (FIGO) (Pattersson,
1989). Clinical parameters, including surgical procedure, post-
operative treatment, response to treatment and follow-up data,
were collected from the medical records. All patients were
followed up until death or March 1997.
Material
Propidium iodide stain (PI; from the Coulter DNA-Prep Reagent
Kit, containing 50 gg ml-' PI, 4 KU ml-1 bovine pancreas type III
RNAase, 0.1% sodium azide, saline and stabilizers) was obtained
from Coulter Corporation (Miami, FL, USA). RPMI medium,
formalin, ethyl alcohol, xylene, pepsin, sodium chloride and
Hanks' solution were obtained from Sigma Chemical (St Louis,
MO, USA).
Methods
Sample preparation
Fresh surgical biopsy ovarian specimens were cut into halves. One
halfofeach tumour was paraffinized to form a tumourblock repre-
senting the cell population in fresh tissue, as confirmed by haema-
toxylin and eosin staining. The second half was immediately put in
ice-cold RPMI medium. From each sample, a single-cell suspen-
sion was made within 30 min of sampling after removal of fat,
blood accumulations, necrotic tissue and normal-looking tissue.
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Table 1 Univariate analysis of riskfactors for relapse and survival in ovarian
carcinoma
Risk factor Relapse Survival
No Yes P-value No Yes P-value
Age
<50 14 12 NS 10 18 NS
.50 14 14 10 16
FIGO stage
or 11 9 0 0.03 0 12 0.03
III 19 26 20 22
Histological type
Serous 20 20 NS 15 23 NS
Non-serous 8 6 5 11
Histological grade
12 7 0.08 4 17 0.03
11 or ilI 16 19 16 17
DNA (fresh)
Diploid 23 5 0.0005 2 26 0.0005
Aneuploid 5 21 18 8
DNA (paraffin)
Diploid 23 11 0.03 8 26 0.009
Aneuploid 5 15 12 8
Table 2 Cox multivariate analysis of risk factors in ovarian carcinoma.
Parameter Wald chi-square P-value Risk ratio
Relapse:
FIGO stage 3.2 0.07
Histological grade 2.3 0.12 -
DNA (fresh) 11.1 0.001 2.8
DNA (paraffin) 3.6 0.06 -
Survival
FIGO stage 3.6 0.06
Histological grade 3.6 0.06 -
DNA (fresh) 9.8 0.002 6.4
DNA (paraffin) 3.9 0.05 -
Table 3 Cox multivariate analysis of risk factors in stage IlIl ovarian
carcinoma
Parameter Wald chi-square P-value Risk ratio
Relapse
Histological grade 1.4 0.3 -
DNA (fresh) 7.1 0.008 2.4
DNA (paraffin) 2.2 0.1 -
Survival
Histological grade 2.4 0.2 -
DNA (fresh) 6.3 0.01 2.2
DNA (paraffin) 2 0.22 -
Mechanical (scissors and scalpel) disaggregation was performed,
and cell clumps were removed by filtration through a50-jim nylon
mesh. After centrifugation, the yield ofcells was calculated (micro-
scopic examination) and split into two parts: one for flow cytom-
etry and one forcytological examination. A sample was considered
representative ifit contained tumour cells greater than 20%
Sections (50 jum) from each paraffin block were deparaffinized
according to Hedley's method, modified by McLemore etal, 1990.
Then, 1 ml of 0.5% prewarmed pepsin in 0.9% saline at pH 1.5
was added to each sample, followed by incubation for 45-60 min
at 36°C, with vortexing at intervals of 10 min. All of the residual
solid tissue was then removed, and the remaining nuclear suspen-
sion was filtered through a 50-jim nylon mesh. The suspension
was then centrifuged at 800 g for 5 min, and the supernatant was
decanted. The pellet was resuspended in 1 ml of Hanks' solution,
centrifuged as before, and the supematant was decanted. The wash
step was repeated twice. The final concentration was adjusted to
106 nuclei ml-'.
After disaggregation, both fresh and paraffinized samples were
stained with propidium iodide, as follows: a 100-jl aliquot ofeach
sample was lysed and stained by the Coulter DNA-Prep, which
sequentially dispenses and mixes 100 jl of lysing permeabilizing
reagent (LPR) and 1 ml ofstaining solution (containing 50jg ml-1
propidium iodide and 4 kU ml-' bovine pancreas type III RNAase)
into each sample. Finally, the samples were incubated at room
temperature for 60 min in darkness before flow cytometric
analysis.
Flowcytometry
Flow cytometric analysis was performed with a Coulter EPICS
Profile II flow cytometer, configured with a 488-nm argon ion
laser. Peripheral blood lymphocytes were used as an external stan-
dard for fresh tissue material. For paraffin-embedded tissue, 50-
jm sections from tonsil block were processed in parallel with each
run and were used as an external standard. A total of20 000 events
per sample were acquired. DNA aneuploidy was defined as any
population with a distinct additional peak(s) or the presence of a
tetraploid population greater than 15%. The CV was defined as the
standard deviation as a percentage of the mean DNA value of the
diploid peak. Samples were excluded when CV exceeded 5%.
Statisticalanalysis
Univariate analyses were performed using a chi-square test of
association or Fisher's exact model to test the association of cate-
gorical variables with relapse and survival. To analyse the simulta-
neous effect of all variables and control for varied follow-up,
Cox's proportional hazards model with Breslow's approximate
likelihood method to handle ties was performed (Cox and Oakes,
1984). The assumptions ofCox's proportional hazards model were
assessed, including interactions and proportionality of hazards
over time. For all analyses, two-sided tests of significance were
performed. All analyses were performed using the Statistical
Package forthe Social Sciences (SPSS) software.
RESULTS
The clinical follow-up period was 5-66 months (mean 36 months).
During the follow-up period, 48% of cases relapsed. Of relapsed
cases, 77% of them died during the follow-up period. Only nine
cases had stage I-II, whereas 83% had FIGO stage III tumours. A
total of 35% had grade I tumours and 65% had grade II-III. Post-
surgical tumour burden in all patients was less than 2 cm. The
results ofthe univariate analysis are shown in Table 1. Irrespective
ofthe variation in the follow-up, significant differences in overall
survival and disease-free survival were found between groups of
patients with respect to stage, grade, and DNA ploidy results
obtained from both fresh and paraffin-embedded tissues.
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Figure 1 Comparison of DNA index for 54 ovarian carcinomas determined
by flow cytometric analysis of fresh and paraffin-embedded samples
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Table 4 Comparison between DNA analysis on fresh tissue vs its paraffin-
embedded tissue
Fresh tissue Paraffinized tissue
Number Significance Number Significance
(P) (P)
Aneuploidy detection rate
Benign samples 0/28 NA 0/28 NA
Malignant samples 26/54 20/54
Prediction of relapse
Relapsed/aneuploid 21/26 15/20
Relapsed/diploid 5/28 0.0005 11/34 0.01
Prediction of survival
Survivors/aneuploid 8/26 8/20
Survivors/diploid 26/28 0.0005 26/34 0.01
Cox multivariate analysis
For relapse NA 0.001 NA NS
For survival NA 0.001 NA NS
NA, not applicable; NS, non-significant.
In the multivariate analysis, DNA ploidy in fresh tissue was the
most significant predictive variable for both relapse and overall
survival. Stage, grade and DNA ploidy in paraffinized tissue also
attained significance. In the second and third steps, DNA ploidy in
paraffinized tissue and stage were introduced into the final Cox
model as shown in Table 2. However, if ploidy results in fresh
tissue were excluded from this final model and DNA ploidy results
in paraffinized tissue were added, it was found to be significant
(P = 0.01). In stage III tumours, only results of DNA ploidy in
fresh tissue were predictive of relapse and survival in the multi-
variate analysis (Table 3).
A comparison ofDNA ploidy obtained from fresh and paraffin-
embedded tissues yielded a correlation coefficient of 0.91 (Figure
1). Corresponding results were obtained in 28 out of 28 (100%)
benign and 46 out of 54 (85%) malignant cases: neither method
detected aneuploidy in any of the benign cases, and both methods
detected diploidy in 28, and aneuploidy in 19 of the 54 malignant
cases (Table 4). The mean value of the CVs for the GJG1 diploid
peaks obtained from fresh tissue analysis was 2 with a range of
1.6-4.2, whereas the mean value ofthe CVs for theG/G, peaks of
the paraffin-embedded tissue was 3.5 with a range of 2-5. The
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Figure 2 (A) DNA histogram of fresh tissue showing the aneuploid peak.
(B) No evidence of aneuploidy in the corresponding paraffin-embedded
tissue
percentage of aneuploid cancer cells ranged from 10% to 80%. In
addition, aneuploidy was found exclusively in fresh sections in
seven cases (Figure 2), and exclusively in the paraffin-embedded
section in one case. Of the seven cases in whose specimens
aneuploidy was detected in fresh tissue exclusively all died of
recurrent disease during the follow-up period.
DISCUSSION
The prognostic significance of flow cytometry DNA ploidy in
ovarian carcinoma has been controversial (Erba et al, 1989; Sahni
et al, 1989). Discrepancies between studies may reflect both
methodological andbiological aspects. The majority ofthe studies,
however, were based on either fresh or paraffin-embedded
specimens. The current study is among the first to examine the
prospective significance of DNA ploidy determined in fresh vs
paraffin-embedded tissue on a group of patients with complete
and clear follow-up data. In this study, we examined 82 ovarian
tumours (54 malignant and 28 benign), from each of which both
fresh and paraffin preparations were made, with the aim of evalu-
ating the use ofthe fixed samples by a prospective follow-up.
Overall, both methods detected aneuploidy in 19 out of 54
(35%) malignant specimens and 0 out of 28 (0%) benign samples,
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yielding a correlation coefficient, or r-value, of 0.91, which
compared favourably with other studies in other neoplasms, with
reported values of 0.55-0.97 (Camplejohn and Macartney, 1985;
Nakamura et al, 1987; Jacobsen et al, 1988a,b; Klami and
Joeysuu, 1988; Grignon et al, 1989; Isobe et al, 1990; Plestring
et al, 1990; De Viata et al, 1991; Krause and Blank, 1992). The
opposing viewpoint, that the flow cytometry ploidy analysis of
fixed tumours may not be satisfactorily reproduced, is supported
by studies that showed DI discrepancies in fresh compared with
fixed tissues (Kallioniemi, 1988; Price and Herman, 1990).
However, detection of aneuploidy was less sensitive in paraffin-
embedded tissue than in fresh tissue. Seven additional aneuploid
cases were detected in fresh tissue exclusively, and one additional
aneuploid case was detected in paraffin-embedded tissue exclu-
sively. Thus, the overall rate of aneuploidy detection was 26 out
of 54 (48%) in the fresh tissue, and 20 out of 54 (37%) in
the paraffin-embedded tissue. Possible explanations for this
discrepancy in frequency of DNA aneuploidy in fresh compared
with paraffin-embedded tissue included heterogeneity of the
tumour itself, differences in tissue fixation and loss or fragility of
tumour nuclei during processing.
The suspension obtained from fresh samples is more representa-
tive ofawhole tumour, whereas in fixed tissues we only analysed a
section of50gm. For this reason, we agree with others (Ljungberg
et al, 1985; De Vita et al, 1991) that analysis with paraffin-
embedded tissue should preferably be performed on different
samples of the same tumour. In fact, the cases that did not corre-
spond were further analysed in sequential sections and stained
overnight. The disappearance of the aneuploid peak found in the
cases analysed in sequential sections indicate the absence ofactual
intratumour heterogeneity in these cases and confirm previous
studies that have characterized DNA ploidy in ovarian carcinoma
as being stable (Friedlander et al, 1984; Volm et al, 1985).
The importance of tissue fixation has been appreciated subse-
quent to the original description of flow cytometry analysis in
paraffin-embedded tissues. Unsatisfactory results of DNA flow
cytometry from paraffin-embedded tissue are more likely to be
caused by failure in fixation rather than the inadequate application
of the flow cytometry method (Feichter and Goerttler, 1986).
External standards can be used in fresh preparations but this is not
possible with paraffin analysis. Differences in fixation and/or
processing as well as differences in chromatin structure of the
control tissue compared with the tumour tissue, can affect the
binding of dyes, specifically the intercalating dyes, resulting in
different fluorescent intensity of diploid nuclei. In the present
study, both ovarian tissue and tonsil tissue were immediately fixed
within 30 min from sampling in a standardized manner. One tonsil
tissue section was processed in parallel with each run of ovarian
specimens. If the tonsil control G!G1 peak CV exceeded 2 s.d. of
our established mean, the optimum instrument performance,
staining were verified and all samples prepared with tonsil control
were reprocessed.
We agree with Schultz and Zarbo that nuclear deterioration,
before or during formalin fixation or during pepsin digestion, may
be the cause of the significant decrease in sensitivity of the
paraffln digestion method shown in the present work (Schultz and
Zarbo, 1992).
Univariate analysis ofour data confirmed the prognostic signif-
icance of known surgical-pathological factors, including FIGO
stage and histological grade (Barabei et al, 1990). We also used
disease-free survival as a measure of poor outcome because very
few patients with recurrent disease survived (6 out of 26). Using
this end point, 48% ofpatients were classified as having persistent
or recurrent disease, which allowed for a meaningful statistical
analysis. Univariate analysis ofevaluated factors demonstrated the
prognostic significance of stage and DNA ploidy results in fresh
and paraffin-embedded tissues with relapse. Multivariate analysis
of these results, controlled for varied follow-up time, showed that
DNA ploidy obtained by fresh tissue analysis was an independent
prognostic factor, superior to other factors for both relapse and
survival. However, when results obtained from the fresh tissue
method were excluded from the final Cox model, DNA ploidy
analysis carried out on paraffinized samples attained significance.
Ofthe seven cases in whose specimens aneuploidy was detected in
fresh tissue exclusively, all died of recurrent disease during the
follow-up period. Using DNA ploidy, acleardistinction was found
between a favourable group with a median survival of more than
48 months and the remaining patients of whom the majority died
during the same follow-up period. When patients were separated
into low stage (I-II) and advanced stage disease (III), DNA
content was a significant prognostic variable for both relapse and
survival in stage III tumours.
Taken together, our findings indicate that data generated by flow
cytometry analysis of formalin-fixed tissue should be interpreted
with caution before the datacan beused to draw clinical inferences.
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